Aristotle University Of Thessaloniki (AUTH)
Μελέτη του λιπιδομικού αποτυπώματος ασθενών με μη αλκοολική λιπώδη νόσο του ήπατος
Abstract
dc:descriptionPatients with non-alcoholic steatohepatitis (NASH) show a significantly faster progression through the stages of liver fibrosis in comparison to patients with simple steatosis (NAFL). Nevertheless, liver biopsy is the only way to diagnose NASH, as the non-invasive diagnosis of NASH remains an unmet clinical need until today. Data from recent animal studies and limited data from bariatric patient studies have shown that sphingolipids, particularly ceramides, fatty acids and other lipid classes may be associated with NASH and its histological disease activity. The present study aimed to investigate whether patients with NASH had a different plasma lipid profile compared to patients with NAFL and healthy controls. This study also aimed to evaluate whether there was an association between the plasma lipid profile and the histological findings in patients with NAFLD. Three groups were included: patients with NASH (N=12), patients with NAFL (N=10) and healthy controls with normal liver (N=15). Plasma samples were collected after overnight fasting and a homogeneous low-fat diet for the previous 24 hours and targeted lipid analyses for fatty acids, acylcarnitines and ceramides were performed. In addition, baseline anthropometric characteristics were recorded and routine biochemical blood tests were performed. Statistical machine learning methods were used to analyze the data. NASH patients did not differ in terms of baseline characteristics from NAFL patients. However, NASH patients had elevated plasma levels of specific fatty acids, including, but not limited to, fatty acids (FA) 14:0, FA 15:0, FA 18:0, FA 18:3n3, and Cer(d18:1/16:0) ceramide, in comparison to NAFL patients. In contrast, although patients with NAFL differed significantly from healthy controls in terms of baseline characteristics, they did not show notable differences in terms of plasma lipid profile. In conclusion, patients with NASH showed a distinct plasma lipidomic signature that may differentiate them from patients with NAFL and healthy controls with normal liver. Further data from well-designed studies with larger sample sizes are needed to validate these findings and to consider potential applications of these findings to disease diagnosis and management strategies.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalopitas, Georgios
- Καλοπήτας, Γεώργιος
Subjects
dc:subject × 14- Μη αλκοολική λιπώδη νόσος του ήπατος
- Μη αλκοολική στεατοηπατίτιδα
- Λιπιδομική
- Μη επεμβατικός δείκτης
- Non alcoholic fatty liver disease
- Non alcoholic steatohepatitis
- Lipidomics
- Non invasive methods
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γαστροεντερολογία
- Clinical Medicine
- Medical and Health Sciences
- Gastroenterology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55070